Features

Viewpoints

All the Guidelines in the World Can’t Eliminate Gray Areas

By

Jim Anderson, MPAS, PA-C, DFAAPA

Publish Date May 31, 2022

Jim Anderson, MPAS, PA-C, explores the role and limits of guidelines.

Adagrasib Shows Promising Activity in Gastrointestinal Cancers

By

Alan P. Lyss, MD

Publish Date February 4, 2022

In the KRYSTAL-1 trial, adagrasib produced a 100% disease control rate in patients with gastrointestinal cancers.

From the Advisory Board

We Can Treat Hodgkin’s Lymphoma Like Melanoma?

By

Isabel Cunningham, MD

Publish Date September 3, 2015

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.

Slideshows

BAVENCIO (avelumab) for Merkel Cell Carcinoma

IMLYGIC (talimogene laherparepvec) for Melanoma

Features

ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type

By

Carina Storrs, PhD

Publish Date March 31, 2023

Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.

Characteristics, Treatment Options for Patients With Advanced Gynecologic Cancers

By

Joyce Pagan

Publish Date March 24, 2023

The management of advanced gynecologic cancers remains a challenge, but the treatment landscape is changing.

Basal Cell Carcinoma: A Review 

By

Lisa Daitch, MPAS, PA-C

McKenzie Lane, PA-C

Publish Date March 21, 2023

Authors present a concise overview of the diagnosis, risk factors, and treatment of basal cell carcinoma.